Molecular sequencing and phenotyping study of chemokines CCL2, CCL5, and CXCL10 in patients with neuroinflammation multiple sclerosis

Ahmed Salim; Ihsan AlSaimary; Amal Adil Kasid Alsudany

doi:10.5114/fn.2025.153300

eISSN: 1509-572x
ISSN: 1641-4640

Folia Neuropathologica

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Send email

Copy url:

Original paper

Molecular sequencing and phenotyping study of chemokines CCL2, CCL5, and CXCL10 in patients with neuroinflammation multiple sclerosis

Ahmed Salim

¹

,

Ihsan AlSaimary

²

,

Amal Adil Kasid Alsudany

³

Department of Medicine, College of Medicine, University of Basrah, Basrah, Iraq
Department of Microbiology, College of Medicine, University of Basrah, Basrah, Iraq
Basrah Health Directorate, Ministry of Health, Basrah, Iraq

Folia Neuropathol 2025; 63:

DOI: https://doi.org/10.5114/fn.2025.153300

Online publish date: 2025/08/11

Article file

- Molecular.pdf [0.99 MB]

Get citation

PlumX metrics:

1. Bielekova B, Martin R. Development of biomarkers in multiple sclerosis. Brain 2004; 127 (Pt 7): 1463-1478.

2. Block K, Gorin Y, New DD, Eid A, Chelmicki T, Reed A, Choudhury GG, Parekh DJ, Abboud HE. The NADPH oxidase subunit p22phox inhibits the function of the tumor suppressor protein tuberin. Am J Pathol 2010; 176: 2447-2455.

3. Brochet B, Ruet A. Cognitive impairment in multiple sclerosis with regards to disease duration and clinical phenotypes. Front Neurol 2019; 10: 261.

4. Bugeja MJ, Booth D, Bennetts B, Heard R, Rubio J, Stewart G. An investigation of polymorphisms in the 17q11.2-12 CC chemokine gene cluster for association with multiple sclerosis in Australians. BMC Med Genet 2006; 7: 64.

5. D’Ambrosio A, Pontecorvo S, Colasanti T, Zamboni S, Francia A, Margutti P. Peripheral blood biomarkers in multiple sclerosis. Autoimmun Rev 2015; 14: 1097-1110.

6. Fazia T, Nova A, Gentilini D, Beecham A, Piras M, Saddi V, Ticca A, Bitti P, McCauley JL, Berzuini C, Bernardinelli L. Investigating the causal effect of brain expression of CCL2, NFKB1, MAPK14, TNFRSF1A, CXCL10 genes on multiple sclerosis: A two-sample mendelian randomization approach. Front Bioeng Biotechnol 2020; 8: 397.

7. Fu Z, Jiang Y, Liu J, Lin Z, Jin Y. Study on plasma CC chemokine ligand 2 level and its promoter region 2518A/G polymorphism in MS patients. Eur J Inflamm 2020; 18.

8. Galimberti D, Scalabrini D, Fenoglio C, Comi C, De Riz M, Venturelli E, Lovati C, Mariani C, Monaco F, Bresolin N, Scarpini E. CXCL10 haplotypes and multiple sclerosis: association and correlation with clinical course. Eur J Neurol 2007; 14: 162-167.

9. Gehad AE, Lichtman MK, Schmults CD, Teague JE, Calarese AW, Jiang Y, Watanabe R, Clark RA. Nitric oxide-producing myeloid-derived suppressor cells inhibit vascular E-selectin expression in human squamous cell carcinomas. J Invest Dermatol 2012; 132: 2642-2651.

10. Hassoun HK, Al-Mahadawi A, Sheaheed NM, Sami SM, Jamal A, Allebban Z. Epidemiology of multiple sclerosis in Iraq: retrospective review of 4355 cases and literature review. Neurol Res 2022; 44: 14-23.

11. Shen R, Lin S, He L, Zhu X, Zhou Z, Chen S, Wang Y, Ding J. Association of two polymorphisms in CCL2 with Parkinson’s disease: A case-control study. Front Neurol 2019; 10: 35.

12. Simonsen CS, Flemmen HØ, Lauritzen T, Berg-Hansen P, Moen SM, Celius EG. The diagnostic value of IgG index versus oligoclonal bands in cerebrospinal fluid of patients with multiple sclerosis. Mult Scler J Exp Transl Clin 2020; 6: 2055217319901291.

13. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 2005; 23: 683-747.

14. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 2018; 17: 162-173.

15. Tumani H, Hartung HP, Hemmer B, Teunissen C, Deisenhammer F, Giovannoni G, Zettl UK; BioMS Study Group. Cerebrospinal fluid biomarkers in multiple sclerosis. Neurobiol Dis 2009; 35: 117-127.

Copyright: © 2025 Mossakowski Medical Research Centre Polish Academy of Sciences and the Polish Association of Neuropathologists. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Molecular sequencing and phenotyping study of chemokines CCL2, CCL5, and CXCL10 in patients with neuroinflammation multiple sclerosis

Ahmed Salim 1 , Ihsan AlSaimary 2 , Amal Adil Kasid Alsudany 3

Ahmed Salim

¹

,

Ihsan AlSaimary

²

,

Amal Adil Kasid Alsudany

³